Navigation Links
Industrial and Environmental pollutants increase diabetes risk

Researchers have found that exposure to pollutants increase the risk of developing Type 2 diabetes. The study was conducted on fisherman families eating// salmon fish containing high levels of chemicals and pollutants known as Persistent Organochlorine Pollutants which includes Polychlorinated biphenyls (PCBs) and DDT.

Type 2 diabetes generally develops after age 40 and can develop gradually, often without symptoms, over many years. It may reveal itself too late to prevent damage. In fact, you may first learn you have diabetes when you develop one of its common complications - heart disease, kidney disease or vision problems.The study results confirmed that eating fish contaminated with industrial and environmental pollutants increased the risk of developing type 2 diabetes.


'"/>




Page: 1

Related medicine news :

1. Industrial Houses to Ensure Medicare for BPL Population
2. Residents Of Former Industrial Towns In UK Most likely To Become Obese
3. Brain disorders caused by Industrial chemicals
4. Industrial Chemicals Are Impairing the Brain Development of Children Worldwide
5. Environmental Factors Found To Have An Impact On The Sex of A Child
6. Environmental Factors Found To Have An Impact On The Sex of A Child
7. Environmental estrogens can cause breast cancer
8. Athletes Are More Prone To Environmental Pollutants Due To Choice Of Diet
9. Environmental Abuse Causes Health Hazards
10. Genes And Environmental Factors Determine Stress Response
11. Air Pollution in Tamil Nadu is a Cause of Concern for Environmentalists
Post Your Comments:
(Date:7/25/2008)...o benefit ALS Therapy Alliance to be presented at ..., WOONSOCKET, R.I., July 25 /PRNewswire/ -- CVS/p...ed a record-breaking $4.4 million in just 21 days,...or ALS research. This is,the seventh year of the a...d more than $15 million for ALS research. This yea...
(Date:7/25/2008)... fluid back-up in esophagus can cause immune syste... News) -- The first evidence linking gastroesophag...overed by Duke University Medical Center researche... was first noted in the 1970s, and since then stud...ent of asthma patients also experience GERD sympto...
(Date:7/25/2008)... New program delivers immediate cost...4-hour telephone access to language interpreters] ...multilingual solutions. , ...E® http://www.lle-inc.com/index.html [(Langu...er of interpretation, translation, and language in...
(Date:7/25/2008)... Whether you are an Olympian, Profes...there are Five Things You Need to Know about Hydra.... Spine and Sports Center , ... America,s premier athletes are heading to Beijing... and sacrifice in the hopes of capturing an Olympi...
Breaking Medicine News(10 mins):Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:People With GERD More Likely to Develop Asthma 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5
...gy segment, pharma major Dr Reddys Laboratories Lt...ailable// in extended release tablets of 10 mg dos...he brand name 'Alfoo' is indicated for treatment o...ing men known as Benign Prostatic Hyperplasia (BPH...
...overed a method to cease the blood supply to cance... cancer//. This, if proved conclusively, will infu...ng to the scientists, a protein, discovered while ...pable of stopping the blood supply to tumors, thus...
...tropolis Health Services (India) plans to make Dub...dle East//. In a joint venture with United Arab Em... Metropolis is set to begin formal operations of i...i in August, though the soft launch took place las...
...ter when investigating for an alternative menopaus...ated hot flashes as good as estrogen. Gabapentin,...the flow of calcium in and out of the cells, which...ature. flow risks like was researchers, who have ...
Other Medicine News:Health News:Metropolis Health Plans Middle East hub in Dubai 2Health News:Gabapentin Reduced Menopausal Symptoms as Estrogen – Study Find 2
(Date:7/23/2008)...CISCO, July 23 /- InCode BioPharmaceu... today announced preclinical test,results demonstr...-1 for,the treatment of the rare chronic blood dis...he complete results will be presented at the XXII,...rland, September 28,2008., The only treatment cu...
(Date:7/22/2008)... efficacy results from a multi-center 293-patient ...oronto Stock Exchange Symbol: CYT, MONTREAL, July...ies,Inc., the global leader in cryotherapy product...at results previously presented from three,Europea...Arctic Front(R),were published earlier today in t...
(Date:7/22/2008)...onstrates Feasibility and Efficacy of Treating Pat...Cancer, SAN FRANCISCO, and YONGIN-SI, South Korea...cisco, CA and Ottawa, Ontario), and its South,Kore... novel findings from,a Phase I clinical trial of i... that the product was well-tolerated and resulted ...
(Date:7/22/2008)...N FRANCISCO, Calif., July 22 /- Hyper... completed patient enrollment,in its Phase 1/2 cli...nd,ammonia scavenging effects of HPN-100 (formally...yrate) in patients with urea cycle disorders,(UCD)...n the fourth quarter,of this year., (Logo: http:...
Breaking Medicine Technology:InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3Speaker judges set for Global Venture Challenge 2483 1STALLERGENES 3A Further Profit Growth Acceleration of R 26D Expenditure 3910 1STALLERGENES 3A Further Profit Growth Acceleration of R 26D Expenditure 3910 2STALLERGENES 3A Further Profit Growth Acceleration of R 26D Expenditure 3910 3Coalition of Consumer Business Union and Advocacy Groups Call for Increased Rx Affordability and Accessibility 14185 1Coalition of Consumer Business Union and Advocacy Groups Call for Increased Rx Affordability and Accessibility 14185 2Coalition of Consumer Business Union and Advocacy Groups Call for Increased Rx Affordability and Accessibility 14185 3Coalition of Consumer Business Union and Advocacy Groups Call for Increased Rx Affordability and Accessibility 14185 4Killer fungus spells disaster for wheat 2480 1Killer fungus spells disaster for wheat 2480 2Killer fungus spells disaster for wheat 2480 3
...Md., March 29, 2007--For depressed people with bip...ding an antidepressant,medication is no more effec...ults published online on March 28, 2007 in the New... of the,large-scale, multi-site Systematic Treatme...BD), a $26.8 million clinical trial,funded by the ...
...lar Ultrasound Demonstrates Utility in Evaluating ...ous Potential for HDL,Therapy , ,PLEASANTON, CA, M...-- Lipid Sciences, Inc. (NASDAQ: LIPD) Dr. H. Brya...Sciences, Inc., concluded from,the wide range of p...diology (ACC) Meeting in New Orleans that the rati...
Other Medicine Technology:Study Sheds Light on Medication Treatment Options for Bipolar,Disorder 2Study Sheds Light on Medication Treatment Options for Bipolar,Disorder 3Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 2Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 3Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 4Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 5
Selecta Trio The pinnacle in the family, combining the Nd:YAG, diode-pumped solid-state (DPSS) 532 Photocoagulator and Q-switched frequency-doubled 532nm laser (SLT) and offering maximum flexibility
Ultimum hemostasis introducers provide outstanding insertion performance, with excellent wire-to-dilator and dilator-to-sheath transitions, high kink resistance and minimal wall thickness. A dual lay
... Haemonetics' latest multi-component platform, whi...the collection of platelets, red cells, plasma, an... possibilities for therapeutic apheresis procedure...llection organizations throughout the world to imp...
The PCS2 system is Haemonetics latest technology for the collection of plasma and flexible protocols allow for the collection of "jumbo" units of platelet-poor plasma, platelet-poor plasma with optio
Medicine Products: